NCT06001073Recruiting
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics (PROSPECT): a National, Multicenter, Retrospective-prospective, Cohort Study
Source: ClinicalTrials.gov · Last updated 12 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and treatment, clarifying the pathogenesis, and providing scientific basis for the prevention and treatment are hot research topics in the study of cardiovascular and cerebrovascular diseases. This study intends to collect clinical data and biological specimen data of patients with cardiovascular and cerebrovascular diseases who meet the inclusion and exclusion criteria, and use multi-omics technology to deeply understand the pathogenic mechanisms of cardiovascular and cerebrovascular diseases and provide new ideas for specific and individualized treatment of patients with cardiovascular and cerebrovascular diseases, to construct early predictive prognostic models and provide a basis for effective treatment of clinical practice in patients with cardiovascular and cerebrovascular diseases.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25000 (estimated)
- First submitted
- 14 Aug 2023
- Start date
- 5 Dec 2022
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- NCT number
- NCT06001073
What you commit to
- Study type: Observational
- Planned participants: 25000
- From 5 Dec 2022 to the primary completion date, 30 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- None of the above was met, but the patient was temporarily unable to sign the informed consent form due to coma and other reasons, and no legal representative signed it instead. Depending on the patient's condition, the patient may not be able to regain consciousness and sign the informed consent form.
Age
- Age \<3 years or \>80 years old;
Other
- Pregnant and lactating women;
- The patient declined to provide informed consent to participate in the study;
Who the study is looking for
- Patients who are regularly visited and followed up in the appropriate patient; department.
- All patients met at least one of the following diagnostic criteria for cardiovascular and cerebrovascular diseases:
- coronary artery disease group;
- arrhythmia group;
- heart valve disease group;
- aortic dissection group;
- cardiac masses group;
- myocarditis group;
- hypertension group;
- cardiomyopathy group;
- structural heart disease group;
- ischemic cerebrovascular disease group;
- hemorrhagic cerebrovascular disease group;
- intracranial space occupying lesion group.
Age in the registry: 3 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| First Affiliated Hospital of Xian Jiantong University Coordinator of this site? Confirm its status | Xi'an | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.